Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Clene Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −1 vs. Q3 2022
- Shares held
- 3.08M
- −1.13M (−26.8%) vs. Q3 2022
- Total value
- $3.09M
- −$8.68M (−73.8%) vs. Q3 2022
- New holders
- 9
- 8 more added
- Sold out
- 10
- 8 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLNN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $19.6M |
| Q1 2026 | 29 | $10.8M |
| Q4 2025 | 28 | $11.4M |
| Q3 2025 | 29 | $4.72M |
| Q2 2025 | 24 | $2.28M |
| Q1 2025 | 24 | $1.40M |
| Q4 2024 | 27 | $2.60M |
| Q3 2024 | 20 | $4.66M |
| Q2 2024 | 37 | $2.40M |
| Q1 2024 | 44 | $3.10M |
| Q4 2023 | 46 | $3.50M |
| Q3 2023 | 47 | $12.3M |
| Q2 2023 | 50 | $28.1M |
| Q1 2023 | 31 | $3.42M |
| Q4 2022 | 35 | $3.09M |
| Q3 2022 | 38 | $12.1M |
| Q2 2022 | 42 | $8.93M |
| Q1 2022 | 53 | $24.7M |
| Q4 2021 | 48 | $26.0M |
| Q3 2021 | 39 | $37.8M |
| Q2 2021 | 35 | $51.6M |
| Q1 2021 | 24 | $31.2M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Clene Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 15 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 100 | $100 | 0.00% | +100 | New |
| Barclays PLC | 140 | $140 | 0.00% | −510−78.5% | Reduced |
| Wells Fargo & Company | 211 | $211 | 0.00% | +77+57.5% | Added |
| Steward Partners Investment Advisory, LLC | 300 | $300 | 0.00% | +300 | New |
| US Bancorp | 400 | $400 | 0.00% | −440−52.4% | Reduced |
| Washington Trust Co | 2,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 3,451 | $3.45K | 0.00% | −33,018−90.5% | Reduced |
| Cutler Group LP | 4,200 | $4.00K | 0.00% | +2,600+162.5% | Added |
| Advisor Group Holdings, Inc. | 5,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 5,200 | $5.00K | 0.01% | +5,200 | New |
| Bank of America Corp | 6,878 | $6.88K | 0.00% | +30+0.4% | Added |
| Tower Research Capital LLC (TRC) | 9,336 | $9.00K | 0.00% | −5,042−35.1% | Reduced |
| UBS Group AG | 9,712 | $9.71K | 0.00% | +3,230+49.8% | Added |
| Two Sigma Investments, LP | 11,970 | $12.0K | 0.00% | −21,429−64.2% | Reduced |
| Susquehanna International Group, LLP | 13,000 | $13.0K | 0.00% | +13,000 | New |
| Morgan Stanley | 16,744 | $16.7K | 0.00% | +3,399+25.5% | Added |
| Jane Street Group, LLC | 23,099 | $23.1K | 0.00% | +23,099 | New |
| Veritable, L.P. | 25,230 | $25.2K | 0.00% | 00.0% | Unchanged |
| Pallas Capital Advisors LLC | 17,341 | $25.8K | 0.00% | 00.0% | Unchanged |
| Belvedere Trading LLC | 27,295 | $27.3K | 0.02% | +27,295 | New |
| Northern Trust Corp | 37,172 | $37.2K | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 55,250 | $55.3K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 68,046 | $68.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 92,290 | $92.0K | 0.00% | −40,125−30.3% | Reduced |
| Bridgeway Capital Management, LLC | 100,774 | $100.8K | 0.00% | +100,774 | New |
| Millennium Management LLC | 117,137 | $117.0K | 0.00% | −92,947−44.2% | Reduced |
| Atom Investors LP | 123,051 | $123.1K | 0.06% | +123,051 | New |
| Group One Trading, L.P. | 126,340 | $126.3K | 0.00% | +126,340 | New |
| BlackRock Inc. | 185,245 | $185.2K | 0.00% | +1,244+0.7% | Added |
| Soltis Investment Advisors LLC | 218,920 | $218.9K | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 230,805 | $230.0K | 0.00% | +9,614+4.3% | Added |
| Laird Norton Trust Company, LLC | 268,581 | $268.6K | 0.04% | 00.0% | Unchanged |
| Kepos Capital LP | 344,427 | $344.0K | 0.05% | −55,573−13.9% | Reduced |
| Vanguard Group Inc | 932,058 | $932.1K | 0.00% | +4450.0% | Added |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −1,100,000−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −81,718−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −52,017−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −29,526−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −20,749−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −19,140−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −12,944−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −2,740−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −247−100.0% | Sold out |
| Morgan Jess S & Co Inc | – | – | – | – | Not filed |
| Jefferies Group LLC | – | – | – | – | Not filed |